HEADER HYDROLASE/HYDROLASE INHIBITOR 07-JAN-03 1NLU TITLE PSEUDOMONAS SEDOLISIN (SERINE-CARBOXYL PROTEINASE) COMPLEXED WITH TWO TITLE 2 MOLECULES OF PSEUDO-IODOTYROSTATIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: SEDOLISIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PSCP, PSEUDOMONAPEPSIN, PEPSTATIN-INSENSITIVE CARBOXYL COMPND 5 PROTEINASE; COMPND 6 EC: 3.4.21.100; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: PSEUDO-IODOTYROSTATIN; COMPND 10 CHAIN: B, C; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS SP.; SOURCE 3 ORGANISM_TAXID: 306; SOURCE 4 GENE: PCP; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 OTHER_DETAILS: THE INHIBITOR WAS CHEMICALLY SYNTHESIZED. KEYWDS PSCP, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.WLODAWER,M.LI,A.GUSTCHINA,Z.DAUTER,K.UCHIDA,H.OYAMA,N.E.GLODFARB, AUTHOR 2 B.M.DUNN,K.ODA REVDAT 3 13-JUL-11 1NLU 1 VERSN REVDAT 2 24-FEB-09 1NLU 1 VERSN REVDAT 1 20-JAN-04 1NLU 0 JRNL AUTH A.WLODAWER,M.LI,A.GUSTCHINA,H.OYAMA,K.ODA,B.B.BEYER, JRNL AUTH 2 J.CLEMENTE,B.M.DUNN JRNL TITL TWO INHIBITOR MOLECULES BOUND IN THE ACTIVE SITE OF JRNL TITL 2 PSEUDOMONAS SEDOLISIN: A MODEL FOR THE BI-PRODUCT COMPLEX JRNL TITL 3 FOLLOWING CLEAVAGE OF A PEPTIDE SUBSTRATE. JRNL REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 314 638 2004 JRNL REFN ISSN 0006-291X JRNL PMID 14733955 JRNL DOI 10.1016/J.BBRC.2003.12.130 REMARK 2 REMARK 2 RESOLUTION. 1.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.164 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : 0.195 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 5501 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 109765 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.124 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.154 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 4124 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 77464 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2752 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 1 REMARK 3 SOLVENT ATOMS : 484 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 3137.00 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 4 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 28486 REMARK 3 NUMBER OF RESTRAINTS : 34716 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 ANGLE DISTANCES (A) : 0.029 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.029 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.074 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.088 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.026 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.042 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.092 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1NLU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JAN-03. REMARK 100 THE RCSB ID CODE IS RCSB017986. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-AUG-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X9B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 110018 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 20.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.77000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.280 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO REMARK 200 SOFTWARE USED: SHELX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: LI2SO4, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 62 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+2/3 REMARK 290 6555 X-Y,X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.12000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 27.56000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 55.12000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 27.56000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 573 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 695 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 ALA A 2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 6 NZ REMARK 480 GLN A 60 CG CD OE1 NE2 REMARK 480 GLN A 75 CD OE1 NE2 REMARK 480 GLN A 76 CG CD OE1 NE2 REMARK 480 GLN A 148 CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN A 60 OE1 GLN A 98 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 124 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ARG A 152 CD - NE - CZ ANGL. DEV. = 11.4 DEGREES REMARK 500 GLN A 160 CG - CD - NE2 ANGL. DEV. = 14.7 DEGREES REMARK 500 ASP A 348 CB - CG - OD1 ANGL. DEV. = 6.3 DEGREES REMARK 500 ARG A 366 NE - CZ - NH1 ANGL. DEV. = -4.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 133 54.92 -91.23 REMARK 500 TYR A 174 44.89 -105.92 REMARK 500 ASP A 183 37.05 -144.30 REMARK 500 ALA A 266 -20.47 -141.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 783 DISTANCE = 5.26 ANGSTROMS REMARK 525 HOH A 838 DISTANCE = 5.10 ANGSTROMS REMARK 525 HOH A 846 DISTANCE = 5.13 ANGSTROMS REMARK 525 HOH A 903 DISTANCE = 5.21 ANGSTROMS REMARK 525 HOH A 910 DISTANCE = 5.59 ANGSTROMS REMARK 525 HOH A 928 DISTANCE = 5.67 ANGSTROMS REMARK 525 HOH A 933 DISTANCE = 5.58 ANGSTROMS REMARK 525 HOH A 945 DISTANCE = 6.45 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 501 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 348 OD2 REMARK 620 2 HOH A 502 O 85.4 REMARK 620 3 GLY A 346 O 98.9 93.1 REMARK 620 4 ASP A 328 OD1 170.9 87.8 87.3 REMARK 620 5 GLY A 344 O 87.5 172.3 91.0 98.9 REMARK 620 6 VAL A 329 O 85.2 91.4 174.1 89.0 85.0 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF PSEUDO-IODOTYROSTATIN REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF PSEUDO-IODOTYROSTATIN REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GA6 RELATED DB: PDB REMARK 900 RELATED ID: 1KDV RELATED DB: PDB DBREF 1NLU A 1 370 UNP P42790 PICP_PSESR 216 585 DBREF 1NLU B 1 3 PDB 1NLU 1NLU 1 3 DBREF 1NLU C 1 3 PDB 1NLU 1NLU 1 3 SEQRES 1 A 370 ALA ALA GLY THR ALA LYS GLY HIS ASN PRO THR GLU PHE SEQRES 2 A 370 PRO THR ILE TYR ASP ALA SER SER ALA PRO THR ALA ALA SEQRES 3 A 370 ASN THR THR VAL GLY ILE ILE THR ILE GLY GLY VAL SER SEQRES 4 A 370 GLN THR LEU GLN ASP LEU GLN GLN PHE THR SER ALA ASN SEQRES 5 A 370 GLY LEU ALA SER VAL ASN THR GLN THR ILE GLN THR GLY SEQRES 6 A 370 SER SER ASN GLY ASP TYR SER ASP ASP GLN GLN GLY GLN SEQRES 7 A 370 GLY GLU TRP ASP LEU ASP SER GLN SER ILE VAL GLY SER SEQRES 8 A 370 ALA GLY GLY ALA VAL GLN GLN LEU LEU PHE TYR MET ALA SEQRES 9 A 370 ASP GLN SER ALA SER GLY ASN THR GLY LEU THR GLN ALA SEQRES 10 A 370 PHE ASN GLN ALA VAL SER ASP ASN VAL ALA LYS VAL ILE SEQRES 11 A 370 ASN VAL SER LEU GLY TRP CYS GLU ALA ASP ALA ASN ALA SEQRES 12 A 370 ASP GLY THR LEU GLN ALA GLU ASP ARG ILE PHE ALA THR SEQRES 13 A 370 ALA ALA ALA GLN GLY GLN THR PHE SER VAL SER SER GLY SEQRES 14 A 370 ASP GLU GLY VAL TYR GLU CYS ASN ASN ARG GLY TYR PRO SEQRES 15 A 370 ASP GLY SER THR TYR SER VAL SER TRP PRO ALA SER SER SEQRES 16 A 370 PRO ASN VAL ILE ALA VAL GLY GLY THR THR LEU TYR THR SEQRES 17 A 370 THR SER ALA GLY ALA TYR SER ASN GLU THR VAL TRP ASN SEQRES 18 A 370 GLU GLY LEU ASP SER ASN GLY LYS LEU TRP ALA THR GLY SEQRES 19 A 370 GLY GLY TYR SER VAL TYR GLU SER LYS PRO SER TRP GLN SEQRES 20 A 370 SER VAL VAL SER GLY THR PRO GLY ARG ARG LEU LEU PRO SEQRES 21 A 370 ASP ILE SER PHE ASP ALA ALA GLN GLY THR GLY ALA LEU SEQRES 22 A 370 ILE TYR ASN TYR GLY GLN LEU GLN GLN ILE GLY GLY THR SEQRES 23 A 370 SER LEU ALA SER PRO ILE PHE VAL GLY LEU TRP ALA ARG SEQRES 24 A 370 LEU GLN SER ALA ASN SER ASN SER LEU GLY PHE PRO ALA SEQRES 25 A 370 ALA SER PHE TYR SER ALA ILE SER SER THR PRO SER LEU SEQRES 26 A 370 VAL HIS ASP VAL LYS SER GLY ASN ASN GLY TYR GLY GLY SEQRES 27 A 370 TYR GLY TYR ASN ALA GLY THR GLY TRP ASP TYR PRO THR SEQRES 28 A 370 GLY TRP GLY SER LEU ASP ILE ALA LYS LEU SER ALA TYR SEQRES 29 A 370 ILE ARG SER ASN GLY PHE SEQRES 1 B 3 IVA PHI TYB SEQRES 1 C 3 IVA PHI TYB MODRES 1NLU PHI B 2 PHE IODO-PHENYLALANINE MODRES 1NLU TYB B 3 TYR TYROSINAL MODRES 1NLU PHI C 2 PHE IODO-PHENYLALANINE MODRES 1NLU TYB C 3 TYR TYROSINAL HET IVA B 1 6 HET PHI B 2 12 HET TYB B 3 12 HET IVA C 1 6 HET PHI C 2 12 HET TYB C 3 12 HET CA A 501 1 HETNAM IVA ISOVALERIC ACID HETNAM PHI IODO-PHENYLALANINE HETNAM TYB TYROSINAL HETNAM CA CALCIUM ION FORMUL 2 IVA 2(C5 H10 O2) FORMUL 2 PHI 2(C9 H10 I N O2) FORMUL 2 TYB 2(C9 H11 N O2) FORMUL 4 CA CA 2+ FORMUL 5 HOH *484(H2 O) HELIX 1 1 ASN A 9 THR A 11 5 3 HELIX 2 2 GLU A 12 TYR A 17 1 6 HELIX 3 3 VAL A 38 ASN A 52 1 15 HELIX 4 4 ASP A 74 ALA A 92 1 19 HELIX 5 5 ASN A 111 ASN A 125 1 15 HELIX 6 6 GLU A 138 ASP A 144 1 7 HELIX 7 7 GLY A 145 GLN A 160 1 16 HELIX 8 8 PRO A 244 VAL A 250 5 7 HELIX 9 9 ALA A 267 GLY A 271 5 5 HELIX 10 10 GLY A 285 ASN A 304 1 20 HELIX 11 11 PRO A 311 THR A 322 1 12 HELIX 12 12 ASP A 357 GLY A 369 1 13 SHEET 1 A 7 TYR A 214 VAL A 219 0 SHEET 2 A 7 ILE A 199 THR A 208 -1 N TYR A 207 O ASN A 216 SHEET 3 A 7 THR A 163 SER A 167 1 N VAL A 166 O ILE A 199 SHEET 4 A 7 VAL A 129 VAL A 132 1 N ILE A 130 O SER A 165 SHEET 5 A 7 ALA A 25 ILE A 35 1 N GLY A 31 O ASN A 131 SHEET 6 A 7 VAL A 96 ALA A 104 1 O LEU A 100 N VAL A 30 SHEET 7 A 7 THR A 59 GLN A 63 1 N ILE A 62 O PHE A 101 SHEET 1 B 3 TYR A 214 VAL A 219 0 SHEET 2 B 3 ILE A 199 THR A 208 -1 N TYR A 207 O ASN A 216 SHEET 3 B 3 ILE A 262 ASP A 265 1 O ILE A 262 N GLY A 202 SHEET 1 C 2 TRP A 136 CYS A 137 0 SHEET 2 C 2 SER A 190 TRP A 191 -1 O TRP A 191 N TRP A 136 SHEET 1 D 2 ASN A 221 LEU A 224 0 SHEET 2 D 2 LEU A 230 ALA A 232 -1 O TRP A 231 N GLY A 223 SHEET 1 E 2 GLY A 236 SER A 242 0 SHEET 2 E 2 ARG A 256 LEU A 259 -1 O LEU A 259 N GLY A 236 SHEET 1 F 2 ALA A 272 ASN A 276 0 SHEET 2 F 2 GLN A 279 ILE A 283 -1 O GLN A 281 N ILE A 274 SHEET 1 G 2 VAL A 326 HIS A 327 0 SHEET 2 G 2 SER A 355 LEU A 356 -1 O SER A 355 N HIS A 327 SSBOND 1 CYS A 137 CYS A 176 1555 1555 2.08 LINK OG SER A 287 C TYB B 3 1555 1555 1.47 LINK CA CA A 501 OD2 ASP A 348 1555 1555 2.38 LINK CA CA A 501 O HOH A 502 1555 1555 2.44 LINK CA CA A 501 O GLY A 346 1555 1555 2.37 LINK CA CA A 501 OD1 ASP A 328 1555 1555 2.34 LINK CA CA A 501 O GLY A 344 1555 1555 2.39 LINK CA CA A 501 O VAL A 329 1555 1555 2.36 LINK C IVA B 1 N PHI B 2 1555 1555 1.33 LINK C PHI B 2 N TYB B 3 1555 1555 1.35 LINK C IVA C 1 N PHI C 2 1555 1555 1.35 LINK C PHI C 2 N TYB C 3 1555 1555 1.33 CISPEP 1 TRP A 191 PRO A 192 0 2.57 CISPEP 2 LEU A 259 PRO A 260 0 0.49 SITE 1 AC1 6 ASP A 328 VAL A 329 GLY A 344 GLY A 346 SITE 2 AC1 6 ASP A 348 HOH A 502 SITE 1 AC2 18 ASP A 74 GLU A 80 TRP A 81 SER A 133 SITE 2 AC2 18 LEU A 134 GLY A 135 TRP A 136 GLY A 169 SITE 3 AC2 18 ASP A 170 GLU A 171 GLU A 175 ARG A 179 SITE 4 AC2 18 SER A 190 GLY A 285 THR A 286 SER A 287 SITE 5 AC2 18 HOH A 736 HOH B 182 SITE 1 AC3 14 GLY A 79 GLU A 80 GLU A 222 TRP A 231 SITE 2 AC3 14 GLN A 268 GLN A 281 ILE A 283 GLY A 284 SITE 3 AC3 14 HOH A 908 HOH C 152 HOH C 288 HOH C 360 SITE 4 AC3 14 HOH C 380 HOH C 442 CRYST1 97.840 97.840 82.680 90.00 90.00 120.00 P 62 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010221 0.005901 0.000000 0.00000 SCALE2 0.000000 0.011802 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012095 0.00000